مثبطات مضخة البروتون تقلل من فعالية بالبو سكلِب في المرضى المصابين بسرطان الثدي النقيل

درس كريادو وزملاؤه هذه المسألة.

www.synapsesocial.com/papers/68e5d9f4b6db643587570168 — DOI: https://doi.org/10.1177/10781552241269677

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer?· 2023 · 16 citations
2. Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib· 2022 · 23 citations
3. The Effect of Food or Omeprazole on the Pharmacokinetics of Osimertinib in Patients With Non‐Small‐Cell Lung Cancer and in Healthy Volunteers· 2017 · 55 citations
4. Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs· 2013 · 264 citations
5. Drug Absorption Interactions Between Oral Targeted Anticancer Agents and PPIs: Is pH-Dependent Solubility the Achilles Heel of Targeted Therapy?· 2012 · 330 citations